Table 2.
HPV | EBV | KSHV | ||||
---|---|---|---|---|---|---|
| ||||||
Infection | Log10 viral loada | Infection | Log10 viral load | Infection | Log10 viral load | |
| ||||||
Unadjusted ORb (95% CIc) p value |
Estimated coefficient (SEd) p value |
Unadjusted OR (95% CI) p value |
Estimated coefficient (SE) p value |
Unadjusted OR (95% CI) p value |
Estimated coefficient (SE) p value |
|
Race | ||||||
Black vs. White (ref.) | 1.84 (0.85–4.01) .122 | - e | - | 1.14 (0.38) .0044 | - | - |
| ||||||
Ethnicity | ||||||
Hispanic vs. Non-Hispanic (ref.) | - | - | - | 0.90 (0.38) .022 | - | - |
| ||||||
Gender | ||||||
Male vs. female (ref.) | - | - | - | - | 10 (1.31–100) .026 | −0.21 (0.13) .107 |
| ||||||
Marijuana use, past 3 months | ||||||
Almost daily/daily vs. weekly or less often (ref.) | 1.83 (0.95–3.52) .069 | - | - | - | - | −0.21 (0.11) .052 |
| ||||||
Tobacco use, past 3 months | ||||||
Almost daily/daily vs. weekly or less often (ref.) | - | - | 2.70 (1.0–7.27) .0496 | 0.53 (0.35) .132 | - | −0.25 (0.11) .029 |
| ||||||
Tobacco use, lifetime | ||||||
Yes vs. no (ref.) | - | 1.55 (0.53) .0052 | - | - | - | - |
| ||||||
Alcohol use, past 3 months | ||||||
Weekly or more often vs. monthly or less often (ref.) | - | - | - | - | 2.14 (0.99–4.59) .052 | - |
| ||||||
Alcohol use, lifetime | ||||||
Yes vs. no (ref.) | - | 1.27 (0.74) .092 | - | - | - | - |
| ||||||
Number of heterosexual sex partners, lifetime | ||||||
1+ vs. 0 (ref.) | 0.19 (0.12) .116 | |||||
| ||||||
Oral sex (performed/received) with condom, past 3 monthsf | 1.06 (1.00–1.13) .069 | |||||
| ||||||
Oral sex (performed/received) without a condom, past 3 months | ||||||
1+ vs. 0 (ref.) | 0.22 (0.13) .108 | |||||
| ||||||
Unprotected oral/anal sex, past 3 monthsg | ||||||
1+ vs. 0 (ref.) | 0.43 (0.17–1.12) .086 | - | - | - | - | 0.28 (0.14) .056 |
| ||||||
CD4+ T cell count | ||||||
<350 cells/mm3 vs. ≥350 cells/mm3 (ref.) | 1.83 (0.96–3.48) .066 | - | 2.67 (0.90–7.90) .076 | 0.66 (0.31) .037 | - | - |
| ||||||
HIV viral load | ||||||
≥400 copies/mL vs. <400 copies/mL (ref.) | - | - | 3.79 (1.74–8.26) .0008 | - | - | - |
| ||||||
Age at HIV diagnosis | ||||||
1–14 years vs. 18–20 years (ref.) | - | - | - | −1.20 (0.47) .014 | - | 0.33 (0.16) .049 |
15–17 years vs. 18–20 years (ref.) | - | - | - | −0.71 (0.38) .069 | - | 0.35 (0.13) .0099 |
| ||||||
HPV vaccination history | ||||||
< 2 doses vs. ≥ 2 doses (ref.) | 2.54 (0.74–8.69) .137 |
Viral loads were normalized to the number of diploid human cells in the specimen as estimated by TaqMan PCR to ERV3 (ERV = endogenous retrovirus), and analyzed as a transformed continuous variable
OR = odds ratio
CI = confidence interval
SE = standard error
Dash indicates that the association was not significant at p < .15
Frequency of oral sex with a condom during the past 3 months with heterosexual partners
Frequency of oral vaginal sex (females only) or anal sex (females and males) without a condom or washing sex toys in between